'No presents anymore': Inside Novartis' scheme to boost Lucentis sales in Greece

In a new deferred prosecution agreement, the DOJ lays out details behind the scheme and the company's efforts to conceal its illicit payments.

From 2012 to 2015, Novartis paid doctors to attend medical congresses in Greece and internationally, with per-doctor expenses sometimes exceeding $6,000 per trip, the document says. Novartis paid for airfare, hotels, and congress registration fees, and the company’s policies stated the trips were to provide medical information.